With breast cancer the most common cancer diagnosed for women in Australia, I-MED Radiology has supported Breast Cancer Trials in recent years throughout Breast Cancer Awareness Month. While more people are being diagnosed with breast cancer each year, thanks to improved screening techniques and treatments, less people are dying from the disease. Without clinical trials research, such as that conducted by Breast Cancer Trials, this wouldn’t be possible.  

Since 2020, I-MED has donated more than $76,000 to Breast Cancer Trials, supporting their mission to discover new and improved breast cancer treatments. In 2023, I-MED will continue this support with a donation of $5 for every mammogram performed throughout Breast Cancer Awareness Month in October to Breast Cancer Trials (projected donation of ~$42,000).

Read more about the impact of Breast Cancer Trials here. 

If you would like to support Breast Cancer Trials, you can make a direct donation via their website here.

The following information is intended to enhance your understanding of breast health, screenings, and proactive wellbeing.

From distinguishing between screening and diagnostic mammograms to learning effective breast check techniques, comprehending different breast cancer types, identifying symptoms and risk factors, and exploring essential statistics, you'll find a wealth of information to support your journey. 

At the heart of this toolkit lies the belief that knowledge is a transformative tool. By understanding breast health intricacies, you're taking charge of your wellness and enabling yourself to advocate for your health with confidence and purpose. 

Breast cancer in Australia

Breast cancer places a heavy burden on individuals, their families and society. For the patient diagnosed with breast cancer, there are physical challenges like surgeries and treatments, along with emotional stress. Families often experience financial strain due to medical expenses and changes in work situations as they provide care and support.  

• More than 20,640 people living in Australia were predicted to be diagnosed with breast cancer in 2022. 
• The five-year survival rate for women diagnosed with breast cancer is 91.8%, and 86.5% for men. 
• A woman’s lifetime risk of being diagnosed with breast cancer in Australia is 1 in 7. For men it is 1 in 726. 

 Find more information on the Breast Cancer Trials website here. 

Mammography

A mammogram is a high-resolution x-ray used to identify breast changes that are suggestive of cancer or may be associated with increased risk of developing breast cancer. Mammograms are non-invasive and can be completed in around 20 minutes.   

The latest technology is 3D mammography (known as tomosynthesis). It is beneficial in the detection of small breast cancers compared with conventional mammography, particularly in women with dense breast tissue, which can mask abnormal areas in a conventional mammogram. In some centers, intravenous contrast may be administered as part of the mammogram examination.

Ultrasound  

A breast ultrasound will often follow a mammography study. It uses high frequency sound waves to produce an image of the tissues within the breast. The combination of the two examinations gives doctors more information, especially in younger patients.

Breast MRI 

Breast MRI uses a magnetic field to take a series of images of the breast tissue. It does not use the ionising radiation of X-rays like a mammogram. It will usually involve an injection of a contrast agent into a vein in the arm during the scan to better visualise the breast tissue and/or abnormalities.

Health practitioners may recommend a breast MRI for women at higher-than-normal risk of breast cancer (i.e., those with genetic factors such as the BRCA 1 or 2 mutation), for women under 50 with dense breast tissue to further characterise a known abnormality on a mammogram/ultrasound or to look for cancer in the opposite breast when it has been found in one breast already.

Breast MRI is also used as a surveillance tool to look for recurrent tumours after previous breast cancer treatment, to gauge the body’s response to treatment such as chemotherapy, and prior to surgery to the breast or lymph glands.

All women should check their breasts regularly between scheduled screenings - although it’s important to remember that self-checking is not a substitute for professional examination. If you notice any changes in your breasts, be sure to see your doctor.

3-step breast check

Educate yourself about breast cancer indicators and the factors that might elevate your risk. By understanding these elements, you're equipped to take swift, informed actions towards your well-being. 

Breast cancer signs and symptoms 

In the early stages of breast cancer there may be no symptoms at all. As the cancer grows, symptoms can include: 

• A new lump in the breast, armpit area or around the collarbone. 
• Change in breast size or shape. 
• Changes to the nipple, such as sores or crusting, an ulcer or inverted nipple. 
• Clear or bloody nipple discharge. 
• Changes to the skin including redness, puckering or dimpling (an ‘orange peel’ appearance). 
• Breast tenderness or pain. 

Risk factors 

A risk factor is something about a person, or what that person is exposed to, that increases their ‘risk’ (in other words, the chance or likelihood) of developing breast cancer in future. It can be genetic or due to a lifestyle factor like alcohol or lack of exercise. Importantly, risk factors don’t tell us everything and the existence of a risk factor, or several risk factors, does not mean a woman will be diagnosed with breast cancer. 

Common risk factors include: 

• Age (75% of women with breast cancer are aged 50+) 
• Excessive alcohol consumption 
• Family history/genetics 
• Breast density 
• Metabolic health 
• Smoking 

All women over age 50 should utilise the free services provided by BreastScreen Australia and schedule regular breast screening.

Breast cancer occurs when abnormal or damaged cells grow in an uncontrolled manner and a tumour is formed. Most tumours start in the milk ducts which carry milk to the nipple. It can develop in both men and women, although it is much less common in men. 

Types of Breast Cancer 

Breast cancer is not just one disease, but several. It includes different subtypes and treatments are becoming increasingly personalised for patients.

Non-invasive breast cancers (carcinoma in situ) are contained within the milk ducts or lobules in the breast and have not grown into the normal breast tissue: 

• Ductal carcinoma in situ (DCIS) – a non-invasive breast cancer that is confined to the milk ducts of the breast. 
• Lobular carcinoma in situ (LCIS) – a non-invasive breast cancer that is confined to the lobules or milk producing glands at the end of the milk ducts of the breast. 

Invasive breast cancers are cancers that are growing in the normal breast tissue and have the potential to spread to other sites in the body: 

• Early breast cancer – an invasive breast cancer that is contained in the breast and may or may not have spread to lymph nodes in the breast or armpit. 
• Paget’s disease of the nipple – a rare form of breast cancer that affects the nipple and the area around the nipple (the areola). Commonly associated with invasive cancer elsewhere in the breast. 
• Inflammatory breast cancer – a rare form of invasive breast cancer that affects the lymphatic vessels in the skin of the breast. This type of breast cancer does not present as a lump but rather a redness or rash in appearance. 
• Locally advanced breast cancer – an invasive breast cancer that is large or has spread to areas near the breast, such as the chest wall. 
• HER2-positive breast cancer – any type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). 
• Triple negative breast cancer – breast cancer that tests negative for all three receptors – oestrogen, progesterone and HER2. 
• Metastatic breast cancer – also known as advanced, secondary or stage 4 breast cancer, which has spread to other parts of the body such as the bones, liver or lungs. 

The above information has been sourced from the Breast Cancer Trials website. 

Our team of content writers create website materials that adhere to the principals set our in content guidelines, to ensure accuracy and fairness for our patients. Dr. Ronald Shnier, our Chief Medical Officer, personally oversees the fact-checking process, drawing from his extensive 30-year experience and specialised training in radiology.